Paganini Life Sciences LLC is categorized under Research and Development Laboratories in Culver City, CA .
Paganini Life Sciences LLC was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Chirst Behrenbruch at the company’s single location by writing to 6140 Bristol Parkway, Culver City, California CA 90230 or by phoning (850) 575-4701. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Paganini Life Sciences LLC |
| Contact Person: | Chirst Behrenbruch |
| Address: | 6140 Bristol Parkway, Culver City, California 90230 |
| Phone Number: | (850) 575-4701 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Paganini Life Sciences LLC was started in 0 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Chirst Behrenbruch for inquiries that concern Paganini Life Sciences LLC by calling the company number (850) 575-4701, as your correspondence is most welcome. Additionally, the physical location of the single location of Paganini Life Sciences LLC can be found at the coordinates as well as the street address 6140 Bristol Parkway in Culver City, California 90230.
For its online presence, you may visit Paganini Life Sciences LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.